AMICUS THERAPEUTICS, INC. — Director's Dealing 2014

Jun 30, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-06-27

Reporting Person: Crowley John F (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-27	Common Stock	M	16491	$0.6375	Acquired	109083	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-27	Stock Options (right to buy)	$0.6375	M	16491	Disposed	2014-08-17	Common Stock (16491)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	64895	Indirect

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consisted of 25% of the total aggregate number of options granted, vested on August 17, 2005. The remaining options vested and became exercisable in a series of thirty-five successive equal monthly installments, beginning on September 1, 2005, with the final installment vesting on August 1, 2009.